Search clinical trials for: Growth Hormone-Releasing Hormone
Total 23117 results
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, GermanyCompleted
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Insud PharmaChemo ResearchCompleted
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
Vanderbilt University Medical CenterNational Institute of General Medical Sciences (NIGMS)CompletedGlucose Intolerance | Glucocorticoids ToxicityUnited States
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Dhanunjaya Lakkireddy, MD, FACCCompleted
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedRheumatoid ArthritisUnited States, Germany, Hungary, Canada, Poland, United Kingdom
-
University Hospital FreiburgNovartis; German Federal Ministry of Education and Research; Deutsche Krebshilfe...CompletedCarcinoma, HepatocellularGermany
-
argenxRecruitingBullous PemphigoidNetherlands, Spain, Germany, United Kingdom, China, Italy, Hungary, United States, Croatia, Japan, Serbia, Bulgaria, Israel, Australia, Greece, Slovakia
-
University of PisaNot yet recruitingSystemic Lupus Erythematosus | Glucocorticoids | Therapy Withdrawal
-
ReveraGen BioPharma, Inc.University of Pittsburgh; Newcastle University; European Union; Cooperative International...CompletedDuchenne Muscular DystrophyUnited States, Belgium, Canada, United Kingdom, Spain, Netherlands, Sweden, Czechia, Australia, Greece, Israel
-
Millennium Pharmaceuticals, Inc.Completed
-
Ottawa Hospital Research InstituteOntario Lung AssociationWithdrawnHIV Infections | TuberculosisCanada, South Africa
-
GlaxoSmithKlineWithdrawn
-
National Institute of Allergy and Infectious Diseases...Completed
-
John SledgeNot yet recruitingOsteoarthritis, KneeUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedAdult Growth Hormone DeficiencyUnited Kingdom, Germany, Australia, Sweden
-
GeneScience Pharmaceuticals Co., Ltd.First Affiliated Hospital, Sun Yat-Sen University; Huazhong University of Science... and other collaboratorsCompletedEfficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children (PD)Growth Hormone Deficiency
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Jin Lu, MDRecruiting
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, Italy, Japan, Poland, Spain, United Kingdom, France, Germany, Greece, Canada, China, Israel, Korea, Republic of, Brazil, Russian Federation, Czechia, New Zealand, Turkey
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Qingdao Central HospitalRecruiting
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Deletion 17P SyndromeItaly
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedMacular Edema | Visual Impairment | Branch Retinal Vein OcclusionGermany, United Kingdom, Hungary, Poland, Czech Republic
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
Assiut UniversityUnknown
-
Peking University People's HospitalQingdao Municipal HospitalRecruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Korea, Republic of, Italy, Taiwan, China, Germany, Israel, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Belgium, Greece, Netherlands
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingCancer | Multiple MyelomaUnited States
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
Saglik Bilimleri UniversitesiCompletedInflammation | Diabetic Macular EdemaTurkey
-
Bristol-Myers SquibbAbbVieNo longer available
-
Seagen Inc.Terminated
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | New Diagnosis TumorItaly
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada